Related Experiment Videos
Effects of baseline comorbidities on cancer screening trial adherence among older African American men
Marvella E Ford1, Suzanne L Havstad, Maya E Fields
1Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, PO Box 250955, Charleston, SC 29425, USA. fordmar@musc.edu
Insights
Older African American men with health conditions generally adhere well to cancer screenings. However, current smoking significantly reduces adherence to all cancer screening types, including prostate, lung, and colorectal cancer screenings.
Area of Science:
- Gerontology
- Public Health
- Oncology
Background:
- Cancer screening adherence is crucial for early detection in older populations.
- Comorbidities may impact participation in health interventions.
- Older African American men represent a population with unique health considerations.
Purpose of the Study:
- To investigate how baseline comorbidities affect cancer screening adherence in older African American men.
- To assess the influence of comorbidities within a case management intervention for cancer screening.
Main Methods:
- A cohort of 683 African American men (age >= 55) was randomized into case management intervention or control groups.
- Baseline comorbidity data were collected and analyzed for their impact on screening adherence rates.
- Statistical analyses examined the relationship between health conditions and adherence to various cancer screenings.
Main Results:
- Participants with comorbidities generally showed similar adherence to trial screenings compared to those without.
- Current smokers exhibited significantly lower adherence to prostate, lung, and colorectal cancer screenings.
- Individuals with chronic bronchitis had reduced adherence to chest X-rays for lung cancer screening.
Conclusions:
- Older African American men with comorbidities are suitable candidates for longitudinal cancer screening trials.
- Smoking cessation is critical, as smoking negatively impacts adherence across all cancer screening modalities.
- Targeted interventions may be needed for specific subgroups, like current smokers, to improve screening participation.
Background:
The purpose of this study was to examine the effects of baseline comorbidities on screening adherence in a sample of older African American men (ages >or=55 years) enrolled in a case management intervention in a cancer screening trial.
Methods:
Baseline comorbidity data were obtained from 683 African American men who were randomly assigned to a case management intervention group (n = 344) or to a case management control group (n = 339). The effects of comorbidities on the screening adherence rates of each group were then assessed.
Results:
No statistically significant interactions were found between each health history characteristic and the intervention. Therefore, analyses were not stratified by intervention status. In general, participants with comorbidities were no less likely to adhere to trial screening than participants without comorbidities. Exceptions were current smokers and participants with chronic bronchitis. Current smokers were less likely than others to adhere to the prostate-specific antigen test (P = 0.02) and the digital rectal examination for prostate cancer screening (P = 0.01), to the chest X-ray for lung cancer screening (P < 0.01), and to the flexible sigmoidoscopy for colorectal cancer screening (P = 0.04). Participants with chronic bronchitis had lower rates of adherence to the chest X-ray (P = 0.06). Having a relative with cancer positively influenced adherence to the digital rectal examination (P = 0.05).
Conclusions:
Overall, older African American men with comorbidities appear to be very good candidates for participation in longitudinal cancer screening trials. However, smoking had a statistically significant and deleterious effect on adherence to all types of screening.
Related Concept Videos
Bias in Epidemiological Studies
Longitudinal Research
Amebiasis